Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

SuraminÀÌ À½°æ ÆíÆò»óÇÇ¾Ï ¼¼Æ÷ÁÖ(CUPE-1)¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ½ÇÇèÀû ¿¬±¸ Experimental Study on the Effect of Suramin on Penile Squamous Carcinoma Cell Line(CUPE-1)

´ëÇѺñ´¢±â°úÇÐȸÁö 1993³â 34±Ç 4È£ p.748 ~ 763
°­ÀϱÔ, ¿À¹®¸ñ,
¼Ò¼Ó »ó¼¼Á¤º¸
°­ÀϱԠ(  ) 
Áß¾Ó´ëÇб³

¿À¹®¸ñ (  ) 
Áß¾Ó´ëÇб³

Abstract


Experimental study was done to investigate the effect of suramin on the in vitro and in vivo proliferation and metastasis of penile squamous carcinoma cell line (CUPE-1) , morphological changes of CUPE-1 cells induced by suramin and mechanism of
action
of suramin.
Suramin inhibited in vitro proliferation of CUPE-1 significantly with IC50 of 100¥ìg/ml media. In vitro antiproliferative effect of suramin on CUPE-1 was reversible after stopping administration of the drug. Weekly intraperitoneal of 200mg/kg of
suramin
to nude mouse inhibited the proliferation and metastasis of intraperitoneally implanted CUPE-1 cells significantly. but did not show significant effect on the proliferation of subcutaneously implanted CUPE-1 cells. Seramin induced senile changes
on
ultrastructure of CUPE-1 cells. Suramin of 300¥ìg/ml inhibited the proliferation-stimulating effect of EGF significantly, whereas, suramin of 100¥ìg/ml did not inhibit the effect of EGF significantly. Suramin did not show significant cytotoxicity
on
3H-thymidine release assay.
These results suggest that suramin is a promising drug for the treatment of advanced penile squamous cell carcinoma and blood level of suramin in clinical trial should be continuously maintained in about 300¥ìg/ml, and that the main machanism of
suramin
against CUPE-1 is cytostatic, by antagonizing the action of EGF and inducing growth arrest an senile change.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS